Mejía-Terrazas GE

Idioma: Español
Referencias bibliográficas: 24
Paginas: 134-136
Archivo PDF: 71.62 Kb.

FRAGMENTO

En nuestro país existe una falta total de Clínicas o Unidades de Dolor Agudo. Los intentos por iniciar con este tipo de proyectos están ubicados en el Instituto Nacional de Ciencias Médicas y la Nutrición, así como en la UMAE, Centro Médico Nacional Siglo XXI, pero no hay una difusión de las mismas y a pesar de que el dolor postoperatorio sigue siendo importante en el paciente quirúrgico, no ha habido un desarrollo paralelo a las clínicas de dolor crónico.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Mayorala V, Gomarb C, Sabatec S, Canetd J, García G, Capse M. Medicina perioperatoria y tratamiento del dolor crónico en Cataluña. Med Clin 2006;126:68-74.

2. Muñoz J, Valentín B, Criado A. Planificación y gestión en el dolor agudo. Unidad de Dolor Agudo En: Torres L. Tratamiento del dolor postoperatorio. Ergon, Madrid, España 2003:329-44.

3. Collado F, Aragón M, Pérez A, Eizaga R, Vidal M, Torres L. Organización de una Unidad de Dolor Agudo en un Hospital Regional. Rev Soc Esp Dolor 2008;15:45-9.

4. Ready L, Oden R, Chadwick H, Benedetti C, Rooke G, Caplan R, Wild L. Development of an anesthesioligy– based postoperative pain management service. Anesthesiology 1986;10:100-106.

5. Richman J, Spencer S, Courpas G, Wong R, Rowlingson A, McGready J, Cohen S, Wu C. Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesth Analg 2006; 102:248-57.

6. Bagry E, De la Cuadra J, Asenjo J, Bracco D, Carli F, Phil M. Effect of a continuous peripheral nerve block on the inflammatory response in knee. Arthroplasty Reg Anesth Pain Med 2008;33:17-23.

7. Denis MG, Lipart C, Leborgne J, LeHur PA, Galmiche JP, Denis M, et al. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer 1997;74:540-4.

8. Bar-Yosef S, Melamed R, Page GG, Shakhar G, Shakhar K, Ben-Eliyanu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001;94:1066-73.

9. Wong IH, Lau WY, Leung T, Johnson PJ. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res 1999;5:4021.

10. Zetter BR. Angiogenesis and tumor metastasis. Annu Rev Med 1998;49:407-24.

11. O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lanes WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-85.

12. Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, et al. The influence of bio-behavioral factors on tumor biology: pathways and mechanisms. Nat Rev Cancer 2006;6:240-8.

13. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 2003;10:972-92.

14. Sacerdote P, Bianchi M, Gaspani L, Manfredi B, Mauricone A, Terno G, et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 2000;90:1411-4.

15. Brand JM, Kirchner H, Poppe C, Schmucker P. The effects of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin Immunol Immunopathol 1997;83:190-4.

16. Beilin B, Shavit Y, Hart J, Mordashov B, Cohn S, Notti I, et al. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 1996;82:492-7.

17. Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, Yee D, et al. Morphine stimulates angiogenesis by activating proangiogenic and survival promoting signaling and promotes breast tumor growth. Cancer Res 2002;62:4491-8.

18. Buggy DJ, Smith G. Epidural anaesthesia and analgesia: better outcome after major surgery? Growing evidence suggests so. BMJ 1999; 319:530-1.

19. O’Riain SC, Buggy DJ, Kerin MJ, Watson RW, Moriarty DC. Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg 2005;100:244-9.

20. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006;105:660-4.

21. Biki B, Mascha E, Moriarty D, Fitzpatrick J, Sessler D, Buggy G. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence A retrospective analysis. Anesthesiology 2008;109:180-7.

22. Schlagenhauff B, Ellwanger U, Breuninger H, Stroebel W, Rassner, Garbe C. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res 2000;10:165-9.

23. Oliveira G Jr, Ahmad S, Schink J, Singh D, Fitzgerald P, McCarthy R. Survival in ovarian cancer patients intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free after primary cytoreductive. Surgery Reg Anesth Pain Med 2011;36:271-277.

24. Esteve Del Rosario E, Giménez I, Montero F, Sánchez M, Baena N, Ferrer A, Aguilar J. Seguridad y efectividad del tratamiento del dolor agudo postoperatorio: seguimiento de 3,670 pacientes. Rev. Esp Anestesiol Reanim 2008;55:541-547